Defined sequences for glycan research
BOC Sciences supports custom oligosaccharide synthesis with specified monosaccharide sequences, glycosidic linkages, stereochemistry, branches, and terminal groups. Projects cover native glycan motifs and deliberately modified analogs for glycan recognition studies, research standards, molecular probes, and drug discovery.
Schematic type 2 LacNAc example: Gal-beta1,4-GlcNAc. R denotes the separately specified reducing-end format; a fixed glycoside also needs its attachment configuration. Other oligosaccharides require their own complete sequence, branches, and modifications.Structure-first project review
Custom glycan synthesis
Biological origin helps identify a research context, but a synthesis target needs an explicit structure. The service areas below distinguish chemical analog design from native glycan families and their defined fragments. Requests can include one structure or a related series with controlled differences in length, branching, substitution, or terminal presentation.
Develop defined glycosaminoglycan fragments with specified backbone residues, uronic acid epimers, and N- or O-substitution patterns. Chain length and total sulfo content alone do not identify the placement of groups along a GAG sequence.
Prepare halogenated glycan analogs with the halogen identity, modified residue, attachment position, and local stereochemistry specified. A site-defined fluorinated analog, for example, represents a particular chemical change rather than a generic replacement for every parent glycan.
Build oligosaccharide analogs containing a specified carbocyclic sugar unit. Replacing a ring oxygen with carbon changes the sugar skeleton and must be distinguished from forming an external C-glycosidic connection at the anomeric center.
Define mammalian glycan motifs, including selected N-glycan, O-glycan, and glycolipid headgroup structures. Core architecture, antenna composition, terminal sugars, and reducing-end format distinguish individual targets within these broad families.
Develop finite bacterial glycan structures from a verified sequence or repeat-unit reference. Species and serotype labels are connected to exact residues, inter-repeat junctions, branches, and native substitutions where relevant.
Prepare defined fragments of fungal glycan motifs, such as specified glucan or mannan sequences, for structure-focused research. Organism names alone do not establish linkage pattern or branch placement, and a fragment does not reproduce the complete organization of a fungal cell wall.
Develop defined plant glycan fragments and selected modified series. Projects can distinguish backbone structure, branch identity, terminal residues, and positional substitutions relevant to a particular plant carbohydrate motif.
Prepare specified human milk oligosaccharide structures and research derivatives with defined lactose-based cores, extensions, fucosylation, or sialylation as applicable. Similar compositions can encode different linkages, so the requested isomer remains an explicit part of the order.
Prepare heparan sulfate oligosaccharides with specified chain lengths, GlcA/IdoA sequences, and N- and O-sulfation patterns. Each target is defined by residue-specific modification positions, both fragment ends, and the supplied ionic form.
Develop defined capsular repeat units and finite oligosaccharide fragments for a specified bacterial species and serotype. Projects address the requested sequence, repeat junctions, branches, and native substitutions, with fragment boundaries and reducing-end functionality defined explicitly.

Project schematic
Specify the complete finite sequence, every bond, branch, and end group. Biological family and residue composition guide the brief but do not substitute for a structural assignment.Target-specific route selection
The number of residues is only one contributor to synthesis complexity. Linkage selectivity, branch accessibility, protecting-group compatibility, enzyme substrate tolerance, and final purification all influence the route. A project-specific plan identifies which structural features need direct control and which possible alternatives must be distinguished analytically.
Chemical assembly offers access to designed residue analogs and protection patterns. Enzymatic steps can introduce selected native linkages when the donor and acceptor are accepted by the enzyme. Combined routes may connect these advantages, but an enzyme that acts on a native substrate cannot be assumed to accept every modified analog.
Map the order of backbone extension, branch construction, and terminal modification. Sialic acids, sulfo groups, phosphates, or other sensitive features can influence deprotection and purification. A reducing-end linker may need to be introduced early, especially when the final product must retain a fixed attachment configuration.
Keep the intended comparison explicit: sequence isomer, branch position, terminal sugar, length, or analog substitution. Match the spacer, immobilization chemistry, and labeling state where those are not the experimental variable. This helps prevent presentation differences from obscuring a glycan-structure comparison.
Structure specification
A probe precursor, a free glycan, and an analytical comparator can share the same carbohydrate sequence while needing different ends, quantities, and acceptance evidence. Define the intended role before selecting the delivery format.
| Research objective | Material format to define | Useful comparison | Acceptance focus |
|---|---|---|---|
| Compare recognition of two linkages | A matched pair differing at one defined glycosidic bond | Parent, linkage isomer, and handle-only control where relevant | Evidence distinguishing the specified linkage and matched presentation |
| Develop an analytical method | A structurally characterized free or derivatized glycan | Relevant isomers or neighboring lengths | Identity, purity method, concentration or content basis, and compatibility with derivatization |
| Prepare a glycan probe | A defined glycan with an agreed reactive end or label | Unlabeled glycan and appropriate label or surface controls | Attachment position, linker identity, and residual free label where applicable |
| Study substitution effects | A parent motif and site-defined modified analogs | Position-matched or unsubstituted comparators | Residue and modification placement, not only total modification count |
| Assess an enzyme substrate | A sequence with compatible ends and required reactive sites | Starting material and structurally defined product comparators | Actual substrate identity and suitability for the chosen assay conditions |
Research standards are supplied against an agreed identity and analytical scope. Suitability for a particular regulated assay, certified reference-material status, or biological performance requires explicit evaluation beyond synthesis alone.
Structure-to-data consistency
Oligosaccharides with equal mass can differ in residue configuration, sequence, linkage, or branching. The characterization plan should therefore identify both the expected product and the structurally relevant alternatives. Different methods contribute complementary information.
Composition
Suitable mass spectrometry supports molecular composition and modification count, while residue analysis can provide complementary composition data. Neither measurement alone establishes the full order and configuration of every bond.
Assignment
NMR, informative MS/MS, suitable enzyme treatments, and comparison with characterized standards can support structural assignment. The combination depends on sample amount, complexity, and the precise distinction that must be resolved.
Uniformity
Chromatography and orthogonal checks are chosen to assess relevant truncations, incomplete extensions, or isomers. A purity value should state its method and detection basis; unresolved isomers may require a separate targeted analysis.
Supplied form
Documentation identifies the actual reducing-end derivative, protection state, label, counterion, or other agreed material feature. For conjugation inputs, the presence of a reactive handle should be supported independently of the glycan headgroup assignment.
Research and method development
Defined material makes it possible to test a specific molecular hypothesis. The synthesis project establishes the glycan and its delivery form; interpretation of recognition, stability, or biological activity remains tied to the experimental system.
Compare lectin, antibody, receptor, or enzyme recognition across selected sequences and isomers. Maintaining equivalent linker and display conditions helps distinguish carbohydrate recognition from differences in surface density or orientation.
Use characterized structures in retention, fragmentation, derivatization, and isomer-separation studies. A comparator can support an assignment only within the resolution and coverage of the analytical method used.
Introduce defined amine, azide, alkyne, biotin, or fluorescent functionality when compatible with the target. Free glycan supply, labeled glycan preparation, and final carrier or surface construction are separately defined deliverables.
Prepare substrate analogs, inhibitor candidates, or glycan fragments for mechanistic and medicinal chemistry research. Chemical resemblance to a native glycan does not establish binding, inhibition, cellular uptake, or therapeutic performance.
A defined research project
BOC Sciences reviews the target as a complete molecule, including its ends and the evidence needed to distinguish related structures. Sequence definition and analytical scope are settled together before route execution.
Project brief
Provide a drawing or unambiguous sequence, a literature reference if available, desired end groups, requested quantity, and intended use. For a series, mark the structural change between members and identify the variables that should remain matched.

Reconcile naming, residue identities, sequence, linkage notation, branches, and boundaries. Separate a native motif from any deliberate analog or derivatization.

Review chemical, enzymatic, or combined approaches, including building-block availability, substrate specificity, protection logic, and sensitive terminal features.

Define the individual structures in a series and select methods for identity, relevant isomers, purity, and end-group confirmation. Set content or concentration reporting when needed.

Prepare the agreed structure and assess the final format. Evaluate partial extension, loss of sensitive groups, or other plausible alternatives as required by the project.

Supply the agreed material with batch-linked analytical records and a clear structure identifier. Distinguish confirmed assignments from any explicitly stated analytical limitations.
Project advantages
The practical value of an oligosaccharide project comes from controlling the structural difference that the study is designed to investigate.
Sequence, topology, terminal caps, and reducing-end chemistry stay linked throughout project review and documentation.
Assembly options are evaluated for the actual linkage and substitution pattern, including difficult analogs and sensitive modifications.
Related targets can be planned around one deliberate change while retaining agreed common presentation features.
The evidence package addresses relevant isomers and incomplete products rather than relying on mass or composition alone.
One connected glycan platform
Related insights
Explore supporting information on structure definition, synthesis, and purification for your glycan research project.
Frequently asked questions
Answers to common questions about structural scope, analytical evidence, and custom synthesis requests.
Provide residue identities and order, linkage positions, anomeric configurations, branch topology, terminal modifications, and both end groups. A composition or a glycan family name does not uniquely define the requested molecule.
Yes. Equal residue counts can encode different sequences, linkages, branches, and stereochemistry. Such isomers can share molecular mass, so the structural assignment and analytical plan must address the distinction relevant to the study.
Route selection considers linkage selectivity, protection requirements, available building blocks, enzyme substrate tolerance, sensitive groups, and purification. Chemical, enzymatic, or combined synthesis is reviewed for the individual target.
Yes, subject to structure and route review. Specify the attachment site, linker, terminal group or label, and final protection state. A reactive glycan precursor and a completed carrier conjugate are separate deliverables.
No. These categories include many structures. Provide a verified sequence or structural reference and define the finite fragment boundaries, branches, native substitutions, and requested end groups.
No. Synthesis establishes a specified molecular product with agreed characterization. Nutritional suitability, biological effects, safety, and any regulated use require their own evidence and project scope.
Define the molecule your study needs
Send the complete glycan sequence, desired presentation format, and the structural comparison your research needs. BOC Sciences can review route options, comparator design, and an analytical package matched to the requested oligosaccharide.
Contact BOC Sciences to discuss the target structure, proposed analytical package, and project-specific specifications. Services are intended for research use.